(Total Views: 156)
Posted On: 07/19/2022 8:34:37 AM
Post# of 74551

$NBIO A Notice of Allowance is issued after the USPTO makes the determination that a patent should be granted from an application.
The allowed patent application, which is titled, "KITS AND CONTAINERS FOR TREATING VIMENTIN EXPRESSING TUMORS" (US Patent Application No. 17/515,010), provides broad protection for Pritumumab ("PTB"
and the storage conditions related to its use in clinical applications.
The allowed patent application, which is titled, "KITS AND CONTAINERS FOR TREATING VIMENTIN EXPRESSING TUMORS" (US Patent Application No. 17/515,010), provides broad protection for Pritumumab ("PTB"


